HGC Investment Management’s Organogenesis Holdings ORGO Stock Holding History

HGC Investment Management’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-728	Closed	-$8K	–	127
2018 Q3	$8K	Hold	728	–	–	﹤0.01%	84
2018 Q2	$8K	Buy	+728	New	+$7.29K	﹤0.01%	68
2018 Q1	–	Sell	-106,728	Closed	-$1.06M	–	59
2017 Q4	$1.06M	Sell	106,728 -238,272	-69%	-$2.37M	0.39%	41
2017 Q3	$3.45M	Sell	345,000 -25,000	-7%	-$248K	1.57%	27
2017 Q2	$3.65M	Buy	+370,000	New	+$3.64M	2.77%	15

HGC Investment Management's ORGO Position: Q4 2018 in Review

HGC Investment Management sold out of Organogenesis Holdings (ORGO) in Q4 2018, closing a stake of 728 shares — an estimated $8K sold.

HGC Investment Management first reported a position in ORGO in Q2 2017 and held it in 5 quarters. The position peaked at $3.65M in Q2 2017. 0 funds tracked by Wall St. Rank hold ORGO as of Q4 2018.

HGC Investment Management reported no remaining Organogenesis Holdings position as of Q4 2018 after selling out during the quarter.
HGC Investment Management sold 728 Organogenesis Holdings shares in Q4 2018, an estimated $8K.
HGC Investment Management first reported a position in Organogenesis Holdings in Q2 2017 and held it in 5 quarters.
HGC Investment Management's Organogenesis Holdings position peaked at $3.65M in Q2 2017.
0 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2018.

Based on HGC Investment Management's 13F filing for Q4 2018, filed 13 Feb 2019.